NCT02540668View on ClinicalTrials.gov

A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Healthy
Interventions
DRUG

Lanabecestat

Administered orally

DRUG

Warfarin

Administered orally

Trial Locations (1)

47710

Covance Clinical Research Inc, Evansville

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

AstraZeneca

INDUSTRY